eScholarshipmetadata only
Peripheral blood biomarkers in PD-1/PD-L1 immunotherapy: distinguishing predictive from prognostic biomarkers
32 biomedical and clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), 3204 immunology (for-2020), cancer (rcdc), minority health (rcdc), clinical trials and supportive activities (rcdc), clinical research (rcdc), health disparities and racial or ethnic minority health research (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 675926
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.